Patent foramen ovale and cryptogenic cerebral infarction

Internal Medicine Journal

Volumn 31, Issue 1, 2001, Pages 42-47

  McGaw, David ^a,b   Harper, R ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Cryptogenic; Foramen ovale; Paradoxical embolism; Patent; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; STROKE;

CEREBRAL INFARCTION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0035009913     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2001.00004.x     Document Type: Review

References (40)

1. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts
2. Images in clinical medicine. Paradoxical embolus
3. Cohort study of multiple brain lesions in sport divers: Role of a patent foramen ovale
4. Brief report: Fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale
5. Prevalence of patent foramen ovale in patients with stroke
6. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Stroke prevention: Assessment of risk in a community
7. Risk of patent foramen ovale for thromboembolic events in all age groups
8. Patent foramen ovale as a risk factor for cryptogenic stroke
9. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly
10. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events
11. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack
12. Patent foramen ovale in young stroke patients
13. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study
14. Identification of patent foramen ovale permitting paradoxic embolism
15. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke
16. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and crptogenic stroke or transient ischemic attack
17. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography
18. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: Report of 80 consecutive cases
19. Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke
20. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology
21. Potential cardioembolic sources in an elderly population without stroke. A transthoracic and transoesophageal echocardiographic study in randomly selected volunteers
22. Frequency of atrial septal aneurysms in patients with cerebral ischemic events
23. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events
24. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause
25. Paradoxical embolism. Diagnosis during life
26. Clinically occult pelvic-vein thrombosis in cryptogenic stroke
27. Venous thromboembolism in acute stroke
28. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism
29. Patent foramen ovale: Is stroke due to paradoxical embolism?
30. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events
31. Percutaneous patent foramen ovale (PFO) closure: It can be done but should it?
32. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: The AFASAK 2 study. Atrial fibrillation aspirin and anticoagulation
33. Clinically silent atrial septal defects with evidence for cerebral embolization
34. Prognosis after stroke followed by surgical closure of patent foramen ovale: A prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound
35. Surgical closure of patent foramen ovale in cryptogenic stroke patients
36. Surgical prophylaxis of recurrent stroke in patients with patent foramen ovale: A pilot study
37. Stroke recurrence in patients with patent foramen ovale: The Lausanne study
38. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement
39. Transcatheter closure of patient foramen ovale after presumed paradoxical embolism
40. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism